| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer
1 company
Romano Kathryn is a Chief Accounting Officer at Krystal Biotech, Inc.. Recent SEC Form 4 filings include 0 buys and 36 sells.
Estimated insider holdings value: $5.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2025 | KRYS Krystal Biotech, Inc. | Chief Accounting Officer | Sale+OE | 750 | $175.22 | $131,415.00 | -5.6% | -28.8% | +59.0% | |
| Feb 28, 2024 | KRYS Krystal Biotech, Inc. | Chief Accounting Officer | Sale+OE | 5,000 | $165.88 | $829,416.89 | -4.6% | -2.5% | +6.3% | |
| Feb 28, 2024 | KRYS Krystal Biotech, Inc. | Chief Accounting Officer | Sale+OE | 7,500 | $166.05 | $1,245,380.71 | -3.7% | -2.5% | +6.3% | |
| Feb 26, 2024 | KRYS Krystal Biotech, Inc. | Chief Accounting Officer | Sale+OE | 8,087 | $136.91 | $1,107,180.00 | -24.4% | +1.3% | +15.4% | |
| Jan 22, 2024 | KRYS Krystal Biotech, Inc. | Chief Accounting Officer | Sale+OE | 2,500 | $130.00 | $325,000.00 | -16.6% | +20.0% | +15.7% | |
| May 22, 2023 | KRYS Krystal Biotech, Inc. | Chief Accounting Officer | Sale+OE | 53,428 | $101.60 | $5,428,115.31 | -30.8% | +6.8% | +41.9% |